ARCHIVES

NCI Support Crucial for Israel cancer Studies; Weizmann Top Recipient

This article is from The Cancer Letter archive.

Vol. 03 No. 24 | June 17, 1977

Download PDF Visit The Full Archive

Related Articles

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

October 25, 2013

Includes April issue of Business & Regulatory Report (8 pages).

May 2, 2003

Richard Pestell To Lead Lombardi Cancer Cente

September 6, 2002

Orlando Hospital Severs MD Anderson Ties, Forming Center with University of Florida

January 10, 2014

ACC Survey Preliminary Finding: Three Cancer DRG Categories “Clearly Underpaid Across The Board”

January 25, 1985

In Brief: Pursell Most Likely To Replace Conte, Foriend Of Cancer Program; DeVita Names Associate

February 15, 1991